Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-042961
Filing Date
2014-06-20
Accepted
2014-06-20 18:35:11
Documents
1
Period of Report
2014-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 39576
  Complete submission text file 0001209191-14-042961.txt   40901
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCYNEXIS, INC. 3501 C TRICENTER BOULEVARD DURHAM NC 27713
Business Address
Ribeill Yves J (Reporting) CIK: 0001604049 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 14933864